Xiamen Amoytop Biotech Co Ltd Net Asset Quality Index
Xiamen Amoytop Biotech Co Ltd net asset quality index. Xiamen Amoytop Biotech Co Ltd (688278) has a Net Asset Quality Index of 85.9% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.21 Billion minus total liabilities of CN¥453.98 Million yields net assets of CN¥2.76 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Xiamen Amoytop Biotech Co Ltd shareholders equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Xiamen Amoytop Biotech Co Ltd (2016–2024)
Net asset quality index of Xiamen Amoytop Biotech Co Ltd from 2016 to 2024. This chart shows how Xiamen Amoytop Biotech Co Ltd's Net Asset Quality Index has evolved across 9 annual periods from 2016 to 2024. As of June 2025, the index stands at 85.9%, representing net assets of CN¥2.76 Billion against total assets of CN¥3.21 Billion CNY. Check Xiamen Amoytop Biotech Co Ltd (688278) strategic investment index to assess the company's strategic physical and investment asset allocation.
Xiamen Amoytop Biotech Co Ltd Net Asset Quality Index by Year (2016–2024)
Xiamen Amoytop Biotech Co Ltd net asset quality index by year from 2016 to 2024. The table below presents the year-by-year Net Asset Quality Index for Xiamen Amoytop Biotech Co Ltd from 2016 to 2024, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Xiamen Amoytop Biotech Co Ltd market cap and net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 83.7% | CN¥2.55 Billion | CN¥3.05 Billion | CN¥497.10 Million | ▲ +4.1 pp |
| 2023 | 79.6% | CN¥1.88 Billion | CN¥2.36 Billion | CN¥479.69 Million | ▲ +0.1 pp |
| 2022 | 79.6% | CN¥1.41 Billion | CN¥1.77 Billion | CN¥360.96 Million | ▼ -1.9 pp |
| 2021 | 81.5% | CN¥1.16 Billion | CN¥1.42 Billion | CN¥262.91 Million | ▼ -2.3 pp |
| 2020 | 83.9% | CN¥1.00 Billion | CN¥1.19 Billion | CN¥192.33 Million | ▲ +12.5 pp |
| 2019 | 71.4% | CN¥563.55 Million | CN¥789.83 Million | CN¥226.27 Million | ▲ +0.8 pp |
| 2018 | 70.5% | CN¥499.26 Million | CN¥707.77 Million | CN¥208.51 Million | ▼ -5.3 pp |
| 2017 | 75.8% | CN¥483.26 Million | CN¥637.12 Million | CN¥153.86 Million | ▲ +1.4 pp |
| 2016 | 74.4% | CN¥478.09 Million | CN¥642.58 Million | CN¥164.49 Million | — |